Given the strong links between EMT and invasiveness and the central role of invasiveness in metastasis, our findings suggest that targeting genes upregulated in our SDC population, including Zeb1, Snail1, Twist2, and Vimentin could offer new therapeutic approaches for RCC. This evidence concerns the gene TWIST2 and renal cell carcinoma.